Metabolic reprogramming and epigenetic effects due to reducing sugars and glycation products in cancer

Savita Bansal, Archana Burman, Taruna Arora, Meenakshi Vachher, Nalini Moza Wali, Bhupender Kumar

Open source

DOI: 10.3389/freae.2025.1752493
Published: 2026-01-27
Container: Frontiers in Epigenetics and Epigenomics
Publisher: Frontiers Media SA
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/freae.2025.1752493,
  title = {Metabolic reprogramming and epigenetic effects due to reducing sugars and glycation products in cancer},
  author = {Savita Bansal and Archana Burman and Taruna Arora and Meenakshi Vachher and Nalini Moza Wali and Bhupender Kumar},
  year = {2026},
  journal = {Frontiers in Epigenetics and Epigenomics},
  doi = {10.3389/freae.2025.1752493},
  url = {https://doi.org/10.3389/freae.2025.1752493}
}

RIS

TY  - JOUR
TI  - Metabolic reprogramming and epigenetic effects due to reducing sugars and glycation products in cancer
AU  - Savita Bansal
AU  - Archana Burman
AU  - Taruna Arora
AU  - Meenakshi Vachher
AU  - Nalini Moza Wali
AU  - Bhupender Kumar
PY  - 2026
JO  - Frontiers in Epigenetics and Epigenomics
DO  - 10.3389/freae.2025.1752493
UR  - https://doi.org/10.3389/freae.2025.1752493
ER  -

APA

Bansal, S., Burman, A., Arora, T., Vachher, M., Wali, N. M., & Kumar, B. (2026). Metabolic reprogramming and epigenetic effects due to reducing sugars and glycation products in cancer. Frontiers in Epigenetics and Epigenomics. https://doi.org/10.3389/freae.2025.1752493

Source records

crossref · retrieved 2026-11-10T20:20:53.122Z